Cwm LLC Sells 292 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Cwm LLC cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.4% in the third quarter, Holdings Channel reports. The firm owned 6,380 shares of the company’s stock after selling 292 shares during the quarter. Cwm LLC’s holdings in Henry Schein were worth $465,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Summit Securities Group LLC bought a new stake in shares of Henry Schein in the 2nd quarter valued at about $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein in the second quarter valued at approximately $37,000. Blue Trust Inc. raised its holdings in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the period. Mather Group LLC. boosted its position in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after purchasing an additional 216 shares in the last quarter. Finally, Palisade Asset Management LLC acquired a new position in shares of Henry Schein in the 1st quarter valued at $113,000. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

NASDAQ:HSIC opened at $72.39 on Friday. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The company has a market cap of $9.27 billion, a P/E ratio of 24.46, a P/E/G ratio of 1.98 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The stock’s 50-day simple moving average is $70.40 and its 200 day simple moving average is $69.88.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The business’s quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.31 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the company. UBS Group reduced their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Evercore ISI boosted their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Friday, September 20th. Finally, Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.